MENU
PSTV
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Plus Therapeutics (PSTV) Ownership - Who owns Plus Therapeutics?
Profile
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.61M
P/E Ratio
N/A
Total Cash
8.44M
Projected Growth
N/A
Total Debt
3.43M
Revenue
N/A
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash/Share
1.43
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PSTV
Capitalization
8.61M
P/E Ratio
N/A
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash
8.44M
Total Cash/Share
1.43
Total Debt
3.43M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-7.63M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
0.50
Current Revenue Per Employee
13176.47
Dividends Per Share - Security
N/A
EBITDA
-8.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.49
Revenue To Assets
-104.14
Shares Held By Institutions
1.04M
Shares Outstanding - Current
5.9M
Total Liabilities
18.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.290
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4200 Marathon Boulevard
Phone
+1 737 255-7194
Employees
20
Web
https://www.plustherapeutics.com